VEGFA and neoplasm: The most recent therapeutic protocols provide for the use of combined chemotherapeutic agents in association with agents targeting specific molecular pathways (i.e., fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), farnesyl-transferase inhibition) or the cellular or acellular components of fibrotic tumor stroma [12].